Yüklüyor......
Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker
Cerebrospinal fluid and positron emission tomography biomarkers accurately predict an underlying Alzheimer's disease (AD) pathology; however, they represent either invasive or expensive diagnostic tools. Therefore, a blood-based biomarker like plasma amyloid beta (Aβ) that could correlate with...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3706955/ https://ncbi.nlm.nih.gov/pubmed/23470128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt162 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|